a column by Lauri Saraste Lauri SARASTE is Chairperson of the Insurance Committee The use of health data in actuarial pricing is increasingly situated at the intersection of technical necessity […]
by Pierre THÉROND and Pierre BOUTONNET by Pierre THÉROND is Partner at Thesseract and Associate Professor at ISFA – Lyon 1 Université Pierre BOUTONNET is Consulting Actuary at Thesseract In […]
by Eytan Ellenberg Dr. Eytan ELLENBERG MD MPH PHD is Head of Research & Academy, Office of Medical Affairs, National Insurance Institute of Israel The implementation of IFRS 17 has […]
AAE submitted a response to EIOPA’s Consultation on the proposal for Guidelines to specify further the qualitative and quantitative indicators in pre-emptive recovery planning. AAE’s submission can be found here. […]
AAE submitted a response to EIOPA’s Consultation on the proposal for Guidelines to specify further the range of scenarios in pre-emptive recovery planning. AAE’s submission can be found here.
by Prof. Dr. Fanny Janssen Prof. Dr. Fanny Janssen was until recent Honorary Professor in ‘Mortality and Longevity’ at the Population Research Centre, Faculty of Spatial Sciences, University of Groningen (NL) […]
by Alban Senn, Mathias Orban and Marvin Schneller Dr. Alban SENN is Chief Medical Officer and Head of Medical R&D (Life/Health) at Munich Re and specialist in internal and intensive […]
interview with Camilla Holm, by Jennifer Baker Camilla HOLM is Group Executive Director Customers & Health at PFA, Denmark With health measurements increasingly focused on prevention of long-term incapacity, Camilla […]
Issue 45, March 2026 of The European Actuary has been published. Featured Articles: Using modelling for a healthy future results in 70% reduction in long-term sickness by combining AI and […]
